Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Feb 14, 2025
SCHEDULE 13G/A Feb 14, 2025
8-K Feb 4, 2025
8-K Dec 3, 2024
8-K Nov 21, 2024
DEFA14A Nov 19, 2024
SC 13G Nov 14, 2024 SC 13G
10-Q Nov 12, 2024
8-K Nov 12, 2024
SC 13G Nov 6, 2024 SC 13G
SC 13G Oct 29, 2024 SC 13G
8-K Oct 18, 2024
DEFA14A Oct 18, 2024
DEF 14A Oct 18, 2024
ARS Oct 18, 2024
EFFECT Oct 17, 2024
EFFECT Oct 15, 2024
CORRESP Oct 15, 2024
UPLOAD Oct 15, 2024
DEL AM Oct 10, 2024
S-3 Oct 9, 2024
POS AM Oct 9, 2024
PRE 14A Oct 7, 2024
D Sep 12, 2024
8-K Aug 30, 2024
← Newer Page 4 of 22 · 545 filings Older →